Table 2 Clinical characteristics of participants associated with Staphylococcus aureus.

From: Oral colonization of antimicrobial-resistant bacteria in home health care participants and their association with oral and systemic status

 

S.aureus

Univariate analysis

 

MRSA

Univariate analysis

 

Variable

Positive

(n = 31)

(n = 31)

Negative

(n = 67)

OR

95% CI

p value

Positive

(n = 8)

Negative

(n = 90)

OR

95% CI

p value

Male sex, n (%)

16(51.6)

22(32.8)

2.18

1.01–4.72

0.1178

4(50.0)

34(37.8)

1.65

0.47–5.83

0.7072

Age ≥ 90 years n, (%)

11(35.5)

20(29.9)

1.29

0.55–3.02

0.643

4(50.0)

27(30.0)

2.33

0.65–8.35

0.2579

OHAT-J score, n(%)

          

Lip score = 1

5(16,1)

8(11.9)

1.42

0.43–4.69

0.5422

1(12.5)

12(13.3)

0.93

0.10–8.09

1.0000

Tongue score = 1, 2

10(32.3)

15(22.4)

1.65

0.67–4.09

0.3258

2(25.0)

23(25.6)

0.97

0.19–4.89

1.0000

Gum and mucosa score = 1, 2

5(16.1)

3(4.5)

4.10

0.92–18.26

0.1047

2(25.0)

6(6.7)

4.67

0.81–27.02

0.1276

Saliva score = 1, 2

7(22.6)

9(13.4)

1.88

0.64–5.51

0.2576

2(25.0)

14(15.6)

1.81

0.35–9.41

0.6135

Natural teeth score = 1, 2

6(19.4)

12(17.9)

1.10

0.38–3.20

1

3(37.5)

15(16.7)

3.00

0.71–12.60

0.1603

Denture score = 1

10(32.3)

5(7.5)

5.90

1.86–18.74

0.0046

4(50.0)

11(12.2)

7.18

1.85–27.81

0.017

Oral cleanliness score = 1, 2

14(45.2)

21(31.3)

1.80

0.81–4.01

0.2569

4(50.0)

31(34.4)

1.90

0.54–6.76

0.4508

Tooth pain score = 1

1(3.2)

2(3.0)

1.08

0.09–12.40

1

1(12.5)

2(2.2)

6.29

0.51–77.12

0.2276

Total score = 3≥

12(38.7)

15(22.4)

2.19

0.92–5.23

0.1434

5(16.1)

22(24.4)

0.39

0.14–1.14

0.1094

Total score = 8≥

3(9.7)

0(0.0)

-

-

0.0296

1(12.5)

2(2.2)

1.08

0.09–12.40

0.2533

Number of

remaining teeth, n (%)

          

0(edentulous)

9(29.0)

14(20.9)

1.55

0.61–3.96

0.4445

2(25.0)

21(23.3)

0.15

0.03–0.68

1.0000

1≥ (With teeth)

22(71.0)

53(79.1)

0.65

0.34–1.24

0.4445

6(19.4)

69(76.7)

2.51

0.82–7.65

1.0000

1–9

5(16.1)

13(19.4)

0.80

0.26–2.44

0.7854

2(25.0)

16(17.8)

-0.01

0.05–1.02

0.6684

10–19

5(16.1)

17(25.4)

0.57

0.19–1.67

0.436

1(12.5)

21(23.3)

0.22

0.01–0.57

0.6791

20≥

12(38.7)

23(34.3)

1.21

0.53–2.74

0.821

4(50.0)

31(34.4)

0.07

0.06–0.53

0.7174

Denture use n, (%)

16(51.6)

35(52.2)

0.91

0.44–1.90

1.0

2(25.0)

49(54.4)

0.27

0.06–1.37

0.1480

FOIS = 1,2,3 n, (%)

1(3.2)

1(1.5)

2.20

0.13–36.34

0.5348

0(0.0)

2(2.2)

-

-

1.0000

Presence of comorbidities, n (%)

          

Dementia

14(45.2)

32(47.8)

0.900735

0.42–1.92

0.8313

5(16.1)

41(45.6)

1.99

0.61–6.46

0.4686

Hypertension

12(38.7)

29(43.3)

0.827586

0.37–1.83

0.826

2(25.0)

39(43.3)

0.44

0.09–2.15

0.4622

Cerebrovascular disease

10(32.3)

18(26.9)

1.296296

0.54–3.13

0.6342

2(25.0)

26(28.9)

0.82

0.16–4.10

1.0000

Cardiovascular disease

8(25.8)

16(23.9)

1.108696

0.43–2.87

1

4(50.0)

20(22.2)

3.50

0.96–12.77

0.0977

Diabetes

9(29.0)

12(17.9)

1.875

0.72–4.91

0.2895

3(37.5)

18(20.0)

2.40

0.58–9.93

0.3627

Fracture

5(16.1)

16(23.9)

0.612981

0.21–1.82

0.4397

2(25.0)

19(21.1)

1.25

0.24–6.34

0.6791

Hyperlipemia

4(12.9)

8(11.99

1.092593

0.31–3.90

1

1(12.5)

11(12.2)

1.03

0.12-9.00

1.0000

Osteoporosis

2(6.5)

10(14.9)

0.393103

0.08–1.90

0.3289

1(12.5)

11(12.2)

1.03

0.12-9.00

1.0000

Back to article page